It releases proteins called autoantibodies that attack healthy cells. Below we provide an overview of some of the most common autoimmune diseases. Doctors don’t know exactly what causes the ...

William Blair analyst Sami Corwin has maintained their bullish stance on CABA stock, giving a Buy rating on November 15.Don't Miss our Black ...

A small trial used designer CAR T cells to reboot the immune systems of patients with three autoimmune diseases, but it's still too early to say whether the treatment works in the long term.

Generation Bio Co. ( (GBIO) ) has released its Q3 earnings. Here is a breakdown of the information Generation Bio Co. presented to its ...

Adicet Bio, Inc. (Nasdaq: ACET), a clinical stage biotechnology company discovering and developing allogeneic gamma delta T ...

Initial data shows strong safety profile and complete B cell depletion ... CAR T Cell Therapy Manufactured Using a Next-generation Process for severe, refractory autoimmune diseases.

Data demonstrate potential superiority of a targeted protein degradation strategy compared to kinase inhibition for both BTK ...

Phase 1 Basket Study for B Cell-mediated Autoimmune Diseases to Assess FT522 as Add ... and eliminated alloreactive T cells, indicating that FT522 has the potential to function effectively in ...